Gebro Pharma GmbH   Report issue

For profit Phase 3 Phase 4
Founded: Fieberbrunn Germany (1947)
Status: Left NME R&D (2019)

Organization Overview

First Clinical Trial
2006
NCT00442585
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Laboratorios Gebro Pharma SA

Active Ingredients

Drugs in Phase 4 Trials (2)

dexibuprofen (1 trial)

ibuprofen (motrin) (2 trials)

Drugs in Phase 3 Trials (1)

hydroxychloroquine (plaquenil) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoarthritis (Phase 4)

Osteoarthritis, Hip (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3